Evidence map›Paper›PMID 40006661›Full record

ArticleVaccines2025

Comparison of Phenotypes of Headaches After COVID-19 Vaccinations Differentiated According to the Vaccine Used.

Carl Hartmut Göbel, Axel Heinze, Katja Heinze-Kuhn, Sarah Karstedt, Mascha Morscheck, Lilian Tashiro, Anna Cirkel, Qutyaba Hamid, Rabih Halwani, Mohamad-Hani Temsah and 4 more

Abstract read
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Carl Hartmut GöbelKiel Migraine and Headache Centre, 24149 Kiel, Germany.
Axel HeinzeKiel Migraine and Headache Centre, 24149 Kiel, Germany.
Katja Heinze-KuhnKiel Migraine and Headache Centre, 24149 Kiel, Germany.
Sarah KarstedtKiel Migraine and Headache Centre, 24149 Kiel, Germany.
Mascha MorscheckKiel Migraine and Headache Centre, 24149 Kiel, Germany.
Lilian TashiroKiel Migraine and Headache Centre, 24149 Kiel, Germany.ORCID 0000-0002-3612-1811
Anna CirkelKiel Migraine and Headache Centre, 24149 Kiel, Germany.
Qutyaba HamidSharjah Institute of Medical Research, University of Sharjah, Sharjah 26666, United Arab Emirates.ORCID 0000-0002-1107-190X
Rabih HalwaniSharjah Institute of Medical Research, University of Sharjah, Sharjah 26666, United Arab Emirates.
Mohamad-Hani TemsahCollege of Medicine, King Saud University, Riyadh 12373, Saudi Arabia.ORCID 0000-0002-4389-9322
Malte ZiemannInstitute of Transfusion Medicine, University Hospital Schleswig-Holstein, Campus Lübeck, 23562 Lübeck, Germany.ORCID 0000-0003-0919-0237
Siegfried GörgInstitute of Transfusion Medicine, University Hospital Schleswig-Holstein, Campus Lübeck, 23562 Lübeck, Germany.
Thomas MünteDepartment of Neurology, University Hospital Schleswig-Holstein, Campus Lübeck, 23562 Lübeck, Germany.
Hartmut GöbelKiel Migraine and Headache Centre, 24149 Kiel, Germany.ORCID 0000-0003-2163-112X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

brainComirnaty (BioNTech)complicationscoronavirus disease 2019COVID-19Covilo (Sinopharm)headachehead-to-head comparisonICHD-3Jcovden (Johnson & Johnson)mRNA vaccinephenotypepostvaccinal headachesSARS-CoV-2 virusspike proteinSpikevax (Moderna)Sputnik V (Gamelaya)vaccinationVaxzevria (AstraZeneca) and Convidecia (CanSino Biologics)

Identifiers

PMID40006661
PMCPMC11861871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.